# Bone Marrow Transplantation in Treating Patients With Lymphoma

> **NCT00002829** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 45 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** Recombinant Interferon Alfa
- **DRUG:** Cyclophosphamide
- **DRUG:** Etoposide
- **DRUG:** Mesna
- **PROCEDURE:** Bone Marrow Transplantation
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00002829
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-02
- **Primary completion:** 2002-04
- **Final completion:** 2002-04
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002829, "Bone Marrow Transplantation in Treating Patients With Lymphoma". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00002829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*